Crescent Biopharma to Present at November Investor Conferences

Rhea-AI Summary

Crescent Biopharma (Nasdaq: CBIO) announced management will present at three investor conferences in November 2025: a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on Nov 11, 2025 at 8:00 a.m. ET in Boston; a fireside chat at the Stifel 2025 Healthcare Conference on Nov 12, 2025 at 1:20 p.m. ET in New York; and a fireside chat at the Jefferies Global Healthcare Conference on Nov 19, 2025 at 9:30 a.m. GMT (4:30 a.m. ET) in London.

Each presentation will be livestreamed from Crescent's investor website and a replay will be accessible for 90 days.

News Market Reaction

-0.08%

2 alerts

-0.08% News Effect

-$146K Valuation Impact

$182M Market Cap

0.4x Rel. Volume

On the day this news was published, CBIO declined 0.08%, reflecting a mild negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $146K from the company's valuation, bringing the market cap to $182M at that time.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November:

• Guggenheim 2^nd Annual Healthcare Innovation Conference, fireside chat on Tuesday, November 11, 2025, at 8:00 a.m. ET in Boston.
  
• Stifel 2025 Healthcare Conference, fireside chat on Wednesday, November 12, 2025, at 1:20 p.m. ET in New York.
  
• Jefferies Global Healthcare Conference, fireside chat on Wednesday, November 19, 2025, at 9:30 a.m. GMT (4:30 a.m. ET) in London.
  

A live webcast of each presentation will be available in the Investors section of Crescent's website at https://investors.crescentbiopharma.com/events-presentations, and a replay will be accessible for 90 days.

About Crescent Biopharma

Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.

Contact:

Amy Reilly
Chief Communications Officer
amy.reilly@crescentbiopharma.com
617-465-0586

FAQ

When will Crescent Biopharma (CBIO) present at the Guggenheim Healthcare Innovation Conference?

Crescent will present a fireside chat on Nov 11, 2025 at 8:00 a.m. ET in Boston.

How can investors watch Crescent Biopharma (CBIO) presentations in November 2025?

Each presentation will be available via live webcast on Crescent's investor website and a replay for 90 days.

What time is Crescent Biopharma (CBIO) on stage at the Stifel 2025 Healthcare Conference?

The fireside chat is scheduled for Nov 12, 2025 at 1:20 p.m. ET in New York.

When is Crescent Biopharma (CBIO) presenting at the Jefferies Global Healthcare Conference in London?

Crescent's fireside chat is set for Nov 19, 2025 at 9:30 a.m. GMT (4:30 a.m. ET).

Where can I find the Crescent Biopharma (CBIO) webcast and replay link?

The live webcast and 90-day replay will be posted in the Investors > Events & Presentations section of Crescent's website.